MA55319A - Procédé de transcription in vitro à alimentation semi-discontinue - Google Patents

Procédé de transcription in vitro à alimentation semi-discontinue

Info

Publication number
MA55319A
MA55319A MA055319A MA55319A MA55319A MA 55319 A MA55319 A MA 55319A MA 055319 A MA055319 A MA 055319A MA 55319 A MA55319 A MA 55319A MA 55319 A MA55319 A MA 55319A
Authority
MA
Morocco
Prior art keywords
semi
vitro transcription
transcription method
discontinue feeding
discontinue
Prior art date
Application number
MA055319A
Other languages
English (en)
Inventor
Joseph Elich
Brian Fritz
Rosalie Philpot
Amy E Rabideau
Michael Shamashkin
Peter Wojciechowski
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of MA55319A publication Critical patent/MA55319A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6865Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q3/00Condition responsive control processes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
MA055319A 2019-03-11 2020-03-11 Procédé de transcription in vitro à alimentation semi-discontinue MA55319A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962816734P 2019-03-11 2019-03-11

Publications (1)

Publication Number Publication Date
MA55319A true MA55319A (fr) 2022-01-19

Family

ID=72426291

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055319A MA55319A (fr) 2019-03-11 2020-03-11 Procédé de transcription in vitro à alimentation semi-discontinue

Country Status (10)

Country Link
US (1) US20220145381A1 (fr)
EP (1) EP3938507A4 (fr)
JP (1) JP2022526089A (fr)
KR (1) KR20210149727A (fr)
CN (1) CN113874502A (fr)
AU (1) AU2020239037A1 (fr)
CA (1) CA3132975A1 (fr)
MA (1) MA55319A (fr)
MX (1) MX2021011031A (fr)
WO (1) WO2020185811A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
WO2017031232A1 (fr) 2015-08-17 2017-02-23 Modernatx, Inc. Procédés de préparation de particules et compositions associées
SI3718565T1 (sl) 2015-10-22 2022-08-31 Modernatx, Inc. Cepiva za respiratorni virus
EA201891001A1 (ru) 2015-10-22 2018-11-30 МОДЕРНАТиЭкс, ИНК. Вакцины на основе нуклеиновых кислот против вируса ветряной оспы (vzv)
EP3364950A4 (fr) 2015-10-22 2019-10-23 ModernaTX, Inc. Vaccins contre des maladies tropicales
AU2016342045A1 (en) 2015-10-22 2018-06-07 Modernatx, Inc. Human cytomegalovirus vaccine
WO2017099823A1 (fr) 2015-12-10 2017-06-15 Modernatx, Inc. Compositions et procédés permettant d'administrer des agents thérapeutiques
MX2019002904A (es) 2016-09-14 2019-09-26 Modernatx Inc Composiciones de arn de alta pureza y métodos para su preparación.
JP6980780B2 (ja) 2016-10-21 2021-12-15 モデルナティーエックス, インコーポレイテッド ヒトサイトメガロウイルスワクチン
EP3538146A4 (fr) 2016-11-11 2020-07-15 ModernaTX, Inc. Vaccin antigrippal
EP3551193A4 (fr) 2016-12-08 2020-08-19 Modernatx, Inc. Vaccins à acide nucléique contre des virus respiratoires
US11384352B2 (en) 2016-12-13 2022-07-12 Modernatx, Inc. RNA affinity purification
MA52262A (fr) 2017-03-15 2020-02-19 Modernatx Inc Vaccin à large spectre contre le virus de la grippe
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
WO2018170270A1 (fr) 2017-03-15 2018-09-20 Modernatx, Inc. Vaccin contre le virus varicelle-zona
EP3595713A4 (fr) 2017-03-15 2021-01-13 ModernaTX, Inc. Vaccin contre le virus respiratoire syncytial
US20200030432A1 (en) 2017-03-17 2020-01-30 Modernatx, Inc. Zoonotic disease rna vaccines
EP3607074A4 (fr) 2017-04-05 2021-07-07 Modernatx, Inc. Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
US11866696B2 (en) 2017-08-18 2024-01-09 Modernatx, Inc. Analytical HPLC methods
WO2019036685A1 (fr) 2017-08-18 2019-02-21 Modernatx, Inc. Procédés pour analyse par clhp
CN111212905A (zh) 2017-08-18 2020-05-29 摩登纳特斯有限公司 Rna聚合酶变体
WO2019046809A1 (fr) 2017-08-31 2019-03-07 Modernatx, Inc. Procédés de fabrication de nanoparticules lipidiques
MA50253A (fr) 2017-09-14 2020-07-22 Modernatx Inc Vaccins à arn contre le virus zika
WO2019148101A1 (fr) 2018-01-29 2019-08-01 Modernatx, Inc. Vaccins à base d'arn contre le vrs
US11851694B1 (en) 2019-02-20 2023-12-26 Modernatx, Inc. High fidelity in vitro transcription
CN113795579A (zh) * 2019-02-20 2021-12-14 摩登纳特斯有限公司 用于共转录加帽的rna聚合酶变体
CN113521268A (zh) 2020-04-22 2021-10-22 生物技术Rna制药有限公司 冠状病毒疫苗
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine
WO2023069900A1 (fr) * 2021-10-18 2023-04-27 Modernatx, Inc. Souche bactérienne personnalisée pour production de protéines recombinantes
CN115260264B (zh) * 2022-02-28 2023-06-09 广州市恒诺康医药科技有限公司 用于rna加帽的化合物及其应用
US11878055B1 (en) 2022-06-26 2024-01-23 BioNTech SE Coronavirus vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3155129T (pt) * 2014-06-10 2019-05-16 Curevac Ag Método para potenciar a produção de arn
MX2019002904A (es) * 2016-09-14 2019-09-26 Modernatx Inc Composiciones de arn de alta pureza y métodos para su preparación.
CN111212905A (zh) * 2017-08-18 2020-05-29 摩登纳特斯有限公司 Rna聚合酶变体

Also Published As

Publication number Publication date
CA3132975A1 (fr) 2020-09-17
MX2021011031A (es) 2021-12-10
KR20210149727A (ko) 2021-12-09
CN113874502A (zh) 2021-12-31
AU2020239037A1 (en) 2021-09-30
US20220145381A1 (en) 2022-05-12
EP3938507A4 (fr) 2023-02-22
EP3938507A1 (fr) 2022-01-19
JP2022526089A (ja) 2022-05-23
WO2020185811A1 (fr) 2020-09-17

Similar Documents

Publication Publication Date Title
MA55319A (fr) Procédé de transcription in vitro à alimentation semi-discontinue
IL279759A (en) Bioreactor for in vitro RNA transcription
SG11202011539VA (en) Modified guide rnas for gene editing
ZA202007633B (en) Modified guide rnas
IL259005A (en) Surfaces for redirecting light and manufacturing methods
SG11201708681SA (en) Method for in vitro transcription using an immobilized restriction enzyme
EP3294880A4 (fr) Arn de guidage unique synthétique pour l'édition de gène médiée par cas9
EP3266900A4 (fr) TÔLE D'ACIER PLAQUÉE D'Al-Zn-Mg-Si EN FUSION ET PROCÉDÉ DE FABRICATION S'Y RAPPORTANT
EP3957629C0 (fr) Procédé de préparation d'hydroxy-benzbromarone deutéré et ses produits intermediaires
MA41380A (fr) Structure en forme de plaque, réservoir et procédé
MA52983A (fr) Procédé de distribution micellaire
PT3294903T (pt) Método para o diagnóstico in vitro da demência com corpos de lewy usando transcritos do gene da alfa-sinucleína
GB201806559D0 (en) Low-pressure upsetting-bulging method for forming hollow member having complex cross-section
MA45725A (fr) Structure en forme de plaque, réservoir et procédé
PL3150295T3 (pl) Maszyna i metoda półciągłego gięcia na zimno sekcji o niskiej ciągliwości
EP3450554A4 (fr) Procédé de criblage in vitro à grande vitesse
EP3437789A4 (fr) Matériau de revêtement en alliage d'aluminium et procédé de production de matériau de revêtement en alliage d'aluminium
FR3033479B1 (fr) Procede de fabrication d'un masque de beaute a support bio-cellulosique et masque associe
IL283901A (en) Process pharmacists and intermediaries
GB2556285B (en) Photomask for optical alignment and optical alignment method
PT3469138T (pt) Método e aparelho para produzir um membro de tração sintético com um comprimento preciso e estabilidade melhorada
SI3093613T1 (sl) Postopek za merjenje in prilagajanje debeline stene cevi
EP3768487C0 (fr) Procédé de micromoulages d'articles
GB201805662D0 (en) Nanostructures and Process For Production
EP3389363B8 (fr) Procédé de floraison in vitro